Shanghai Junshi Biosciences Co Ltd
SSE:688180
Shanghai Junshi Biosciences Co Ltd
Cash & Cash Equivalents
Shanghai Junshi Biosciences Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shanghai Junshi Biosciences Co Ltd
SSE:688180
|
Cash & Cash Equivalents
¥3.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Beigene Ltd
HKEX:6160
|
Cash & Cash Equivalents
¥15B
|
CAGR 3-Years
33%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash & Cash Equivalents
¥11.4B
|
CAGR 3-Years
108%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash & Cash Equivalents
¥3.8B
|
CAGR 3-Years
75%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash & Cash Equivalents
¥6.3B
|
CAGR 3-Years
68%
|
CAGR 5-Years
54%
|
CAGR 10-Years
20%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash & Cash Equivalents
¥3.1B
|
CAGR 3-Years
84%
|
CAGR 5-Years
71%
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai Junshi Biosciences Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
3.8B
CNY
Based on the financial report for Dec 31, 2023, Shanghai Junshi Biosciences Co Ltd's Cash & Cash Equivalents amounts to 3.8B CNY.
What is Shanghai Junshi Biosciences Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
6%
Over the last year, the Cash & Cash Equivalents growth was -37%. The average annual Cash & Cash Equivalents growth rates for Shanghai Junshi Biosciences Co Ltd have been 4% over the past three years , 6% over the past five years .